MyoD is a basic helix-loop-helix transcription factor involved in the
activation of genes encoding skeletal muscle-specific proteins. Indepe
ndent of its ability to transactivate muscle-specific genes, MyoD can
also act as a cell cycle inhibitor. MyoD activity is regulated by tran
scriptional and posttranscriptional mechanisms. While MyoD can be foun
d phosphorylated, the functional significance of this posttranslation
modification has not been established. MyoD contains several consensus
cyclin-dependent kinase (CDK) phosphorylation sites. In these studies
, we examined whether a link could be established between MyoD activit
y and phosphorylation at putative CDK sites. Site-directed mutagenesis
of potential CDK phosphorylation sites in MyoD revealed that S200 is
required for MyoD hyperphosphorylation as well as the normally short h
alf-life of the MyoD protein. Additionally, we determined that turnove
r of the MyoD protein requires the proteasome and Cdc34 ubiquitin-conj
ugating enzyme activity. Results of these studies demonstrate that hyp
erphosphorylated MyoD is targeted for rapid degradation by the ubiquit
in pathway. The targeted degradation of MyoD following CDK phosphoryla
tion identifies a mechanism through which MyoD activity can be regulat
ed coordinately with the fell cycle machinery (CDK2 and CDK4) and/or c
oordinately with the cellular transcriptional machinery (CDK7, CDK8, a
nd CDK9).